Press release NNIT Announces Partnership with SAP to collaborate on IDMP NNIT collaborates with SAP to deliver leading IT software and services for identification of medicinal products (IDMP) tailored to improve the reporting and tracking of product ...
NNIT Announces Partnership with SAP to collaborate on IDMP
NNIT collaborates with SAP to deliver leading IT software and services for identification of medicinal products (IDMP) tailored to improve the reporting and tracking of product safety.
Copenhagen, October 5, 2016 - NNIT, a global provider of IT services and consultancy, today announced a worldwide partnership with SAP SE, the market leader in enterprise application software, to market leading solutions supporting regulatory compliance for Identification of Medicinal Products (IDMP) within the pharmaceutical industry.
The European Medicines Agency (EMA) is implementing five new standards developed by the International Organization for Standardization (ISO). Pharmaceutical companies will be required to submit data on medicines to EMA in accordance with common global formats and terminologies. The penultimate goal as defined by the EMA is to improve overall patient safety.
Committed to support these new regulatory requirements, NNIT will introduce tailored, innovative solutions intended to secure successful IDMP compliance within the authority timelines.
Rasmus Nelund, Vice President for Life Sciences at NNIT explained:
"The situation calls for solutions tailored to the global pharmaceutical regulatory environment. While sharing with SAP a strong dedication to life sciences and a documented legacy within the pharmaceutical industry, we look forward to delivering fully integrated services for robust IT throughout the pharmaceutical product life cycle."
SAP delivers world-class enterprise application software that allows end-to-end process support including master data management and consolidation, text analysis, approval workflow and message exchange support. NNIT provides wall-to-wall IT services including infrastructure, architecture, design, development, implementation, application maintenance, support and hosting.
Joe Miles, Global Vice President for Life Sciences at SAP, noted:
"The partnership between NNIT and SAP has existed for more than a decade, delivering business value during implementations for SAP enterprise applications, including the SAP Advanced Track and Trace for Pharmaceuticals application. By collaborating on IDMP, we combine the powerful capabilities of the SAP HANA platform together with NNIT's regulatory expertise and profound legacy within IT services outsourcing for the life sciences industry."
NNIT delivers international consultancy in IT from early stage development to implementation, validation and operation. Serving a growing number of clients from life sciences, NNIT knows how to create business value while fulfilling the strictest regulatory requirements. By applying the latest advances in technology NNIT makes software, business processes and communication more effective. Currently NNIT A/S has more than 2,600 employees. For more information please visit www.nnit.com.
Helga Heyn, NNIT Communications, +45 30 77 81 41, email@example.com
SAP, SAP HANA and other SAP products and services mentioned herein as well as their respective logos are trademarks or registered trademarks of SAP SE (or an SAP affiliate company) in Germany and other countries. See http://www.sap.com/corporate-en/legal/copyright/index.epx for additional trademark information and notices. All other product and service names mentioned are the trademarks of their respective companies.
SAP Forward-Looking Statement
Any statements contained in this document that are not historical facts are forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Words such as "anticipate," "believe," "estimate," "expect," "forecast," "intend," "may," "plan," "project," "predict," "should" and "will" and similar expressions as they relate to SAP are intended to identify such forward-looking statements. SAP undertakes no obligation to publicly update or revise any forward-looking statements. All forward-looking statements are subject to various risks and uncertainties that could cause actual results to differ materially from expectations The factors that could affect SAP's future financial results are discussed more fully in SAP's filings with the U.S. Securities and Exchange Commission ("SEC"), including SAP's most recent Annual Report on Form 20-F filed with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of their dates.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: NNIT A/S via Globenewswire
Source(s) : NNIT A/S
Søborg/Copenhagen, November 4, 2016 Market Abuse Regulation Art. 19 reporting of transactions Pursuant to Market Abuse Regulation Art. 19, the following transactions in shares and associated securities of NNIT A/S have been reported by ...
NNIT A/S ("NNIT"), a leading provider of IT services and consultancy announces that on October 28, 2016 it has received the following notification pursuant to Section 29 of the Danish Securities Trading Act regarding Chr. Augustinus ...